Oxymorphone (brand name: Opana) is an opioid analgesic designed to provide relief for chronic or severe pain. This painkiller is prescribed to provide a long-term pain solution around the clock and is not intended to be an as-needed pain reliever.
Sources
Department of Drug Enforcement. Drug scheduling. DEA. (n.d.). Retrieved November 17, 2021, from https://www.dea.gov/drug-information/drug-scheduling
MedlinePlus. Oxymorphone. (n.d.). Retrieved November 17, 2021, from https://medlineplus.gov/druginfo/meds/a610022.html
Mayo Clinic (n.d.). Oxymorphone (Oral Route). (n.d.) Retrieved November 17, 2021, from https://www.mayoclinic.org/drugs-supplements/oxymorphone-oral-route/side-effects/drg-20071555
Health Resources and Services Administration. Opioid Crises. (n.d.). Retrieved November 17, 2021, from https://www.hrsa.gov/opioids
Center for Drug Evaluation and Research. (n.d.). Oxymorphone (marketed as Opana ER) information. U.S. Food and Drug Administration. Retrieved December 22, 2021, from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/oxymorphone-marketed-opana-er-information